ArticleFrontiers in oncology2022

Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.

Yongmei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.